290 related articles for article (PubMed ID: 34604280)
41. Disrupted fatty acid distribution in HDL and LDL according to apolipoprotein E allele.
Dang TM; Conway V; Plourde M
Nutrition; 2015 Jun; 31(6):807-12. PubMed ID: 25933487
[TBL] [Abstract][Full Text] [Related]
42. Dried blood spot omega-3 and omega-6 long chain polyunsaturated fatty acid levels in 7-9 year old Zimbabwean children: a cross sectional study.
Mashavave G; Kuona P; Tinago W; Stray-Pedersen B; Munjoma M; Musarurwa C
BMC Clin Pathol; 2016; 16():14. PubMed ID: 27499701
[TBL] [Abstract][Full Text] [Related]
43. Changes in lipoprotein particle subclasses, standard lipids, and apolipoproteins after supplementation with n-3 or n-6 PUFAs in abdominal obesity: A randomized double-blind crossover study.
Grytten E; Laupsa-Borge J; Bohov P; Bjørndal B; Strand E; Skorve J; Nordrehaug JE; Berge RK; Rostrup E; Mellgren G; Dankel SN; Nygård OK
Clin Nutr; 2021 May; 40(5):2556-2575. PubMed ID: 33933722
[TBL] [Abstract][Full Text] [Related]
44. Omega-3 fatty acid supplementation influences the whole blood transcriptome in women with obesity, associated with pro-resolving lipid mediator production.
Polus A; Zapala B; Razny U; Gielicz A; Kiec-Wilk B; Malczewska-Malec M; Sanak M; Childs CE; Calder PC; Dembinska-Kiec A
Biochim Biophys Acta; 2016 Nov; 1861(11):1746-1755. PubMed ID: 27531277
[TBL] [Abstract][Full Text] [Related]
45. Combination of n-3 polyunsaturated fatty acids reduces atherogenesis in apolipoprotein E-deficient mice by inhibiting macrophage activation.
Takashima A; Fukuda D; Tanaka K; Higashikuni Y; Hirata Y; Nishimoto S; Yagi S; Yamada H; Soeki T; Wakatsuki T; Taketani Y; Shimabukuro M; Sata M
Atherosclerosis; 2016 Nov; 254():142-150. PubMed ID: 27744130
[TBL] [Abstract][Full Text] [Related]
46. EPA and DHA reduce LPS-induced inflammation responses in HK-2 cells: evidence for a PPAR-gamma-dependent mechanism.
Li H; Ruan XZ; Powis SH; Fernando R; Mon WY; Wheeler DC; Moorhead JF; Varghese Z
Kidney Int; 2005 Mar; 67(3):867-74. PubMed ID: 15698426
[TBL] [Abstract][Full Text] [Related]
47. Effects of maternal n-3 fatty acid supplementation on placental cytokines, pro-resolving lipid mediators and their precursors.
Keelan JA; Mas E; D'Vaz N; Dunstan JA; Li S; Barden AE; Mark PJ; Waddell BJ; Prescott SL; Mori TA
Reproduction; 2015 Feb; 149(2):171-8. PubMed ID: 25504868
[TBL] [Abstract][Full Text] [Related]
48. Modification of subcutaneous white adipose tissue inflammation by omega-3 fatty acids is limited in human obesity-a double blind, randomised clinical trial.
Fisk HL; Childs CE; Miles EA; Ayres R; Noakes PS; Paras-Chavez C; Kuda O; Kopecký J; Antoun E; Lillycrop KA; Calder PC
EBioMedicine; 2022 Mar; 77():103909. PubMed ID: 35247847
[TBL] [Abstract][Full Text] [Related]
49. Differential effects of EPA versus DHA on postprandial vascular function and the plasma oxylipin profile in men.
McManus S; Tejera N; Awwad K; Vauzour D; Rigby N; Fleming I; Cassidy A; Minihane AM
J Lipid Res; 2016 Sep; 57(9):1720-7. PubMed ID: 27170732
[TBL] [Abstract][Full Text] [Related]
50. Divergent shifts in lipid mediator profile following supplementation with n-3 docosapentaenoic acid and eicosapentaenoic acid.
Markworth JF; Kaur G; Miller EG; Larsen AE; Sinclair AJ; Maddipati KR; Cameron-Smith D
FASEB J; 2016 Nov; 30(11):3714-3725. PubMed ID: 27461565
[TBL] [Abstract][Full Text] [Related]
51. Relationship between diet and plasma long-chain n-3 PUFAs in older people: impact of apolipoprotein E genotype.
Samieri C; Lorrain S; Buaud B; Vaysse C; Berr C; Peuchant E; Cunnane SC; Barberger-Gateau P
J Lipid Res; 2013 Sep; 54(9):2559-67. PubMed ID: 23801662
[TBL] [Abstract][Full Text] [Related]
52. Clinical response to EPA supplementation in patients with major depressive disorder is associated with higher plasma concentrations of pro-resolving lipid mediators.
Lamon-Fava S; Liu M; Dunlop BW; Kinkead B; Schettler PJ; Felger JC; Ziegler TR; Fava M; Mischoulon D; Rapaport MH
Neuropsychopharmacology; 2023 May; 48(6):929-935. PubMed ID: 36635595
[TBL] [Abstract][Full Text] [Related]
53. Docosahexaenoic and Eicosapentaenoic Intervention Modifies Plasma and Erythrocyte Omega-3 Fatty Acid Profiles But Not the Clinical Course of Children With Autism Spectrum Disorder: A Randomized Control Trial.
de la Torre-Aguilar MJ; Gomez-Fernandez A; Flores-Rojas K; Martin-Borreguero P; Mesa MD; Perez-Navero JL; Olivares M; Gil A; Gil-Campos M
Front Nutr; 2022; 9():790250. PubMed ID: 35425788
[TBL] [Abstract][Full Text] [Related]
54. Diets enriched in menhaden fish oil, seal oil, or shark liver oil have distinct effects on the lipid and fatty-acid composition of guinea pig heart.
Murphy MG; Wright V; Ackman RG; Horackova M
Mol Cell Biochem; 1997 Dec; 177(1-2):257-69. PubMed ID: 9450671
[TBL] [Abstract][Full Text] [Related]
55. Incorporation of n-3 fatty acids into plasma lipid fractions, and erythrocyte membranes and platelets during dietary supplementation with fish, fish oil, and docosahexaenoic acid-rich oil among healthy young men.
Vidgren HM; Agren JJ; Schwab U; Rissanen T; Hänninen O; Uusitupa MI
Lipids; 1997 Jul; 32(7):697-705. PubMed ID: 9252957
[TBL] [Abstract][Full Text] [Related]
56. Circulating triacylglycerol and apoE levels in response to EPA and docosahexaenoic acid supplementation in adult human subjects.
Buckley R; Shewring B; Turner R; Yaqoob P; Minihane AM
Br J Nutr; 2004 Sep; 92(3):477-83. PubMed ID: 15469651
[TBL] [Abstract][Full Text] [Related]
57. Use of manufactured foods enriched with fish oils as a means of increasing long-chain n-3 polyunsaturated fatty acid intake.
Lovegrove JA; Brooks CN; Murphy MC; Gould BJ; Williams CM
Br J Nutr; 1997 Aug; 78(2):223-36. PubMed ID: 9301413
[TBL] [Abstract][Full Text] [Related]
58. Eicosapentaenoic and docosahexaenoic acids have different effects on peripheral phospholipase A2 gene expressions in acute depressed patients.
Su KP; Yang HT; Chang JP; Shih YH; Guu TW; Kumaran SS; Gałecki P; Walczewska A; Pariante CM
Prog Neuropsychopharmacol Biol Psychiatry; 2018 Jan; 80(Pt C):227-233. PubMed ID: 28648567
[TBL] [Abstract][Full Text] [Related]
59. Plasma and rectal mucosal oxylipin levels during aspirin and eicosapentaenoic acid treatment in the seAFOod polyp prevention trial.
Fuller H; Race AD; Fenton H; Burke L; Downing A; Williams EA; Rees CJ; Brown LC; Loadman PM; Hull MA
Prostaglandins Leukot Essent Fatty Acids; 2023 May; 192():102570. PubMed ID: 37003144
[TBL] [Abstract][Full Text] [Related]
60. Bioavailability of long chain omega-3 polyunsaturated fatty acids from phospholipid-rich herring roe oil in men and women with mildly elevated triacylglycerols.
Cook CM; Hallaråker H; Sæbø PC; Innis SM; Kelley KM; Sanoshy KD; Berger A; Maki KC
Prostaglandins Leukot Essent Fatty Acids; 2016 Aug; 111():17-24. PubMed ID: 27151222
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
